Medtronic PLC closed 8.69% short of its 52-week high of $96.25, which the company reached on March 10th.

Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.

According to Benzinga Pro, Medtronic's peer group average for short interest as a percentage of float is 4.55%, which means ...

Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

Hologic (Nasdaq: HOLX) announced that it appointed Wayde McMillan to its board of directors, effective April 4, 2025.

Adam Savage of "MythBusters" sat down with Fox News Digital to explore the science of healthy and longer lives after forming ...

Medtronic has inked a neurovascular partnership with Methinks AI, a Barcelona, Spain-based developer of programs to detect ...

Last week, US President Donald Trump signed an executive order on the so-called "reciprocal tariffs", imposing a 10 percent ...

Medtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.

In the latest market close, Medtronic (MDT) reached $87.89, with a -1.09% movement compared to the previous day. The stock exceeded the S&P 500, which registered a loss of 4.84% for the day. Meanwhile ...